Company Description

Medicus Pharma Ltd., a biotech/life sciences company, focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets.

It develops SkinJect, with an indication for basal cell carcinoma that is drug device combination product using novel dissolvable microneedle arrays for the treatment of non-melanoma skin cancers.

The company was founded in 2015 and is headquartered in Toronto, Canada.

Medicus Pharma Ltd.

Country	Canada
Founded	2008
Industry	Drug Manufacturers - General
Sector	Healthcare
CEO	Raza Bokhari

Contact Details

Address: One First Canadian Place, Suite 3400 Toronto, ON M5X 1A4 Canada
Website	medicuspharma.com

Stock Details

Ticker Symbol	MDCX
Exchange	NASDAQ
Reporting Currency	USD
CIK Code	0001997296
ISIN Number	CA58471K2020
Employer ID	98-1778211
SIC Code	2834

Key Executives

Name	Position
Dr. Raza Bokhari M.B.A., M.D., MBA	Chief Executive Officer and Executive Chairman
Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D.	Chief Scientific Officer and Head of Research & Development Program
Carolyn Bonner	President
Anna Baran-Djokovic J.D.	Senior Vice President of Investor Relations
Viktoriia Slepeniuk	Senior Vice President of Public Relations
Maryann Adesso	Chief of Staff
Dr. Faisal Mehmud M.D.	Chief Medical Officer

Latest SEC Filings

Date	Type	Title
Jun 13, 2025	PRE 14A	Other preliminary proxy statements
Jun 6, 2025	424B3	Prospectus
Jun 6, 2025	424B3	Prospectus
Jun 6, 2025	253G2	Acc-no: 0001493152-21-027927 (33 Act)
Jun 6, 2025	424B3	Prospectus
Jun 5, 2025	8-K	Current Report
Jun 3, 2025	424B3	Prospectus
Jun 3, 2025	424B3	Prospectus
Jun 3, 2025	424B3	Prospectus
Jun 3, 2025	253G2	Acc-no: 0001493152-21-027927 (33 Act)

View All SEC Filings